Exploring the convergence of biology, engineering and materials science to understand how the human body could be repaired, regenerated, replaced and enhanced.
Explore Inocule ↗What happens when the boundaries between biology and engineering begin to disappear?
Inocule Group explores emerging technologies across genetics, cellular engineering, regenerative medicine, neurotechnology, bioprinting, advanced materials and bionics.
About the Group ↗
The Theseus Paradox asks whether an object remains the same when its components are gradually replaced. Inocule applies this ancient question to the human body.
If biological structures can be regenerated, organs replaced, neural systems connected to machines and capabilities restored or enhanced—where does restoration end and transformation begin?
Research areas spanning the biological, physical and computational systems that may shape the next generation of human health.
Editing the instructions of life.
Building biological structures for a regenerative future.
Connecting the nervous system with advanced computing.
Engineering systems that restore physical function.
Exploring the body's ability to repair and regenerate.
Building scalable medicines and pharmaceutical capabilities.
One operating pharmaceutical business and a portfolio of future technology platforms.
Affordable generic medicines and scalable pharmaceutical manufacturing.
Genetic medicine and gene-editing technologies.
Neural interfaces connecting biology and computation.
Engineered tissues and regenerative manufacturing.
Engineering systems that restore and extend physical function.
Cellular and tissue-based approaches to biological restoration.
Research begins the process. Evidence determines what moves forward.
Identify emerging scientific opportunities.
Assess scientific, practical and commercial potential.
Create products, companies or partnerships where appropriate.
Inocule Group is exploring what comes next.
Delaware · Silicon Valley · Hyderabad
Contact Inocule ↗